Nephroworld Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 44.24%
- Profit Growth 1136.34%
- Ebitda 148.17%
- Net Worth 83.45%
- Total Assets 5.28%
About Nephroworld
Nephroworld Private Limited (NPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 03 October 2016 (Eight years and four months 0 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mahesh Kallor, Arun Kalluvettayyathu, Roy Joy, and One other member serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85310KA2016PTC096914
-
Company No.
096914
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Oct 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Nephroworld?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Kallor
|
Director | 03-Oct-2016 | Current |
|
Arun Kalluvettayyathu
|
Director | 03-Oct-2016 | Current |
|
Roy Joy
|
Director | 03-Oct-2016 | Current |
|
Anupam Ashok
|
Director | 03-Oct-2016 | Current |
Financial Performance of Nephroworld.
Nephroworld Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.24% increase. The company also saw a substantial improvement in profitability, with a 1136.34% increase in profit. The company's net worth Soared by an impressive increase of 83.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nephroworld?
In 2023, Nephroworld had a public holding of 0.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Arpith Enterprises Private LimitedMahesh Kallor is a mutual person
-
Nephroxw Health Care Private Limited
Anupam Ashok is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nephroworld?
Nephroworld has a workforce of 27 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nephroworld, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nephroworld's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.